Researchers develop synthetic proteins that rewire cancer cells by co-opting critical disease-associated pathways while also sparing healthy tissue. Findings were confined to cells grown in the laboratory, but could eventually lead to a new type of cancer therapy.

See the source article by following the link below:
Researchers develop synthetic proteins that rewire cancer cells by co-opting critical disease-associated pathways while also sparing healthy tissue. Findings were confined to cells grown in the laboratory, but could eventually lead to a new type of cancer therapy.